Cempra Pharmaceuticals Closes $46 Million Series C Financing

Cempra Pharmaceuticals, Inc., a clinical-stage company developing novel antibiotics for difficult-to-treat and drug-resistant infections, announced today that it has successfully raised $46 million in a Series C financing.... [more]

View complete Press Release article